Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentric Open-label Randomized Controlled Study for Evaluating the Improvement of Endothelial Function in Stage II Peripheral Arterial Obstructive Disease Patients Treated With Sulodexide + Conventional Treatment {CT] Vs CT Alone

NCT03370705 is registered in ClinicalTrials.gov with Alfa Wassermann Tunisia as lead sponsor.

NCT NCT03370705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03370705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentric Open-label Randomized Controlled Study for Evaluating the Improvement of Endothelial Function in Stage II Peripheral Arterial Obstructive Disease Patients Treated With Sulodexide + Conventional Treatment {CT] Vs CT Alone
Lead sponsor
Alfa Wassermann Tunisia
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 2019
Completion date
March 30, 2020
Enrollment
156 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial obstructive disease